Domain
Clinical
EHR, ICD-10, LOINC, SNOMED CT, patient care and clinical documentation
16,101 clinical terms
The clinical outcome or diagnostic finding associated with an adverse food or drug intolerance evaluation, such as a confirmed reaction, negative challenge result, or test finding. Used to document the conclusion of an intolerance assessment and guide future treatment or avoidance protocols.
A version or iteration counter tracking updates made to an adverse food or drug intolerance record over time. Supports audit trail requirements in clinical data systems by identifying when an intolerance entry was modified, by whom, and how many times the record has been revised since initial documentation.
A clinical assessment of the potential danger level associated with a patient's exposure to a known intolerance trigger, such as a food allergen or drug substance. Used to stratify patients by intolerance-related risk and inform clinical alerts, prescribing safeguards, and care plan modifications.
The administration pathway through which a substance was introduced when an adverse intolerance reaction occurred, such as oral, intravenous, or topical. Documented in clinical records to contextualize the reaction, support causality analysis, and guide future substance administration decisions.
A calculated or clinician-assigned numeric rating quantifying the severity or clinical significance of an adverse food or drug intolerance. Used in clinical decision support and population health reporting to prioritize patient safety interventions and standardize intolerance severity comparisons across patient records.
A numeric ordering value assigned to an adverse food or drug intolerance record within a patient's clinical history. Used to organize multiple intolerance entries chronologically or by clinical priority, ensuring accurate sequencing when displaying or processing intolerance records in clinical information systems.
A coded or descriptive classification indicating the clinical seriousness of a patient's adverse food or drug intolerance reaction, ranging from mild to life-threatening. Used to guide clinical alerts, treatment planning, and medication prescribing decisions to prevent recurrence of harmful reactions.
The patient's biological sex recorded in the context of an adverse food or drug intolerance record. Used to support epidemiological analysis, clinical research, and population health reporting by identifying sex-based patterns in intolerance prevalence, reaction types, and severity across patient populations.
The originating system, clinician, or data feed from which an adverse food or drug intolerance record was captured or imported. Used to assess data provenance and reliability, supporting data governance, clinical reconciliation workflows, and the merging of intolerance records across disparate healthcare systems.
The date on which a patient's adverse food or drug intolerance was first identified, diagnosed, or reported. Recorded in clinical systems to establish the onset of the intolerance episode, support duration calculations, and provide historical context for prescribing, dietary planning, and longitudinal care management.
The specific time of day at which an adverse food or drug intolerance reaction began or was first documented. Used alongside the start date in clinical records to create a precise timestamp for the onset event, supporting reaction timelines, pharmacovigilance reporting, and clinical incident documentation.
The geographic state or province associated with the location where an adverse food or drug intolerance was documented or where the patient resided at time of recording. Used in clinical and administrative data systems for regional reporting, public health surveillance, and jurisdictional data compliance requirements.
The current clinical state of a documented adverse food or drug intolerance record, such as active, inactive, resolved, or entered-in-error. Used in clinical systems to filter and display relevant intolerance records, drive medication safety alerts, and ensure that care decisions are based on current and accurate patient intolerance data.
The concentration or dosage strength of a drug or substance associated with a documented adverse intolerance reaction. Recorded in clinical systems to provide context for the exposure that triggered the reaction, supporting pharmacovigilance, prescribing avoidance rules, and threshold-based clinical decision support.
A partial aggregated value calculated within an adverse food or drug intolerance dataset, typically representing a subset of records or reactions grouped for reporting or scoring purposes. Used in clinical analytics to produce intermediate totals for intolerance burden assessments or population health summaries.
The date of a surgical procedure associated with or documented in relation to an adverse food or drug intolerance record. Captured in clinical systems where an operative event is relevant to the intolerance history, such as pre-surgical allergy screening or intraoperative adverse drug or anesthetic reactions.
The destination system, record, or clinical entity to which an adverse food or drug intolerance record is linked or directed, such as a referenced medication order or care plan. Used in clinical data integration workflows to establish directional relationships between intolerance records and actionable clinical documentation.
Standardized classification code identifying the category of an adverse food or drug intolerance within clinical systems. Used to consistently classify and cross-reference intolerance records across EHR platforms, enabling accurate clinical decision support and patient safety alerts.
Body temperature measurement recorded at the time an adverse food or drug intolerance reaction was observed or reported. Captured as part of the clinical assessment to document physiological responses and support diagnostic evaluation of the intolerance event in patient records.
Date on which a documented food or drug intolerance record was clinically resolved, inactivated, or determined to be no longer applicable. Used to define the active period of the intolerance and ensure clinical decision support alerts reflect only current, relevant patient safety information.